Literature DB >> 27053867

Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats.

J M Yang1, D W Han1, Q C Liang1, J L Zhao1, S Y Hao1, X H Ma1, Y C Zhao1.   

Abstract

AIM: To evaluate the relationship between expression of ras, p53 and bcl-2 gene products and hepatocarcinogenesis since the endotoxemia produced from lipopolysaccharide administration and/or the hypophagocytic state of splenectomy significantly accelerated hepatocarcinogenesis induced by thioacetamide.
METHODS: The hepatocarcinoma model was induced by 6-mo oral intake of 0.03% thioacetamide. During the hepatocarcinoma modeling process, rats were additionally treated with splenectomy and/or lipopolysaccharide administration. The techniques of flow cytometry, immunohistochemistry and immunoelectronmicroscopy were applied for quantitative analysis of the expression of oncogene proteins.
RESULTS: In this model system, overexpression of ras p21 protein mainly occurred in the precancerous cell population or in cells in the early stage of hepatocyte transformation. The levels of ras p21 declined when nuclear DNA aneuploidy increased. Expression of bcl-2 protein slowly and steadily rose, with more hepatocytes staying in S + G2M phases, as the hepatocarcinoma became more malignant. p53 was moderately expressed during hepatocarcinogenesis. There was no statistical correlation between endotoxemia levels and the changes in levels of ras, p53 and bcl-2 gene products.
CONCLUSION: Overexpression of oncogene ras p21 was considered likely to be a precursor of premalignant hepatocytes and possibly as responsible for the initiation of hepatocarcinogenesis. Bcl-2 protein expression is proportional to the severity of malignancy in hepatocarcinogenesis. p53 may be involved in a key pathway underlying the transformation and development processes of hepatocarcinoma. This study confirmed the hypothesis that there are multiple genes and multiple steps involved in hepatocarcinogenesis. Expression of oncogene proteins reflects the properties of the premalignant and malignant cells, but is not directly related to endotoxemia statistically.

Entities:  

Keywords:  Gene expression; Genes, p53; Genes, ras; Liver neoplasms; Oncogene proteins; Thioacetamide

Year:  1997        PMID: 27053867      PMCID: PMC4806235          DOI: 10.3748/wjg.v3.i4.213

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

Review 1.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 2.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

Review 3.  Chemical carcinogenesis: from animal models to molecular models in one decade.

Authors:  S H Yuspa; M C Poirier
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

4.  Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.

Authors:  E Campo; O de la Calle-Martin; R Miquel; A Palacin; M Romero; V Fabregat; J Vives; A Cardesa; J Yague
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

5.  Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

Authors:  T Miyashita; J C Reed
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

6.  Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia.

Authors:  M Zhao; N X Zhang; M Economou; I Blaha; J A Laissue; A Zimmermann
Journal:  Histopathology       Date:  1994-09       Impact factor: 5.087

7.  Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.

Authors:  J C Reed; L Meister; S Tanaka; M Cuddy; S Yum; C Geyer; D Pleasure
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

8.  An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes.

Authors:  T Iwaki; M Miyazono; T Hitosumatsu; J Tateishi
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 9.  Bcl-2 and the regulation of programmed cell death.

Authors:  J C Reed
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

10.  High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy.

Authors:  T Kihana; H Tsuda; S Teshima; S Okada; S Matsuura; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-09
View more
  1 in total

1.  Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissues.

Authors:  Zhao-Shan Niu; Bo-Kian Li; Mei Wang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.